Medicine & Life Sciences
HIV
100%
Hepatitis B virus
37%
Integrases
34%
Incidence
34%
Eastern Europe
34%
Confidence Intervals
31%
Mortality
24%
Integrase Inhibitors
24%
Cohort Studies
24%
Hepatitis D
22%
Hepatitis Delta Virus
21%
Hepacivirus
21%
abacavir
21%
Tuberculosis
19%
Coinfection
18%
Hepatitis C
16%
Antiviral Agents
15%
dolutegravir
15%
Hepatocellular Carcinoma
15%
Cardiovascular Diseases
14%
Therapeutics
13%
RNA
13%
Chronic Hepatitis B
13%
Neoplasms
12%
Rilpivirine
12%
CD4 Lymphocyte Count
11%
Prospective Studies
11%
Denmark
11%
Hepatitis
10%
Cryptococcal Meningitis
10%
JTK 303
10%
Pharmaceutical Preparations
10%
Cystatin C
9%
Raltegravir Potassium
9%
Acquired Immunodeficiency Syndrome
9%
Southeastern Asia
9%
HIV Infections
9%
End Stage Liver Disease
9%
Lymphoproliferative Disorders
9%
Viremia
8%
Emphysema
8%
Liver Cirrhosis
8%
Africa South of the Sahara
8%
Delayed Diagnosis
8%
Population
8%
Hepatitis B
8%
efavirenz
7%
Observational Studies
7%
Interferons
7%
Blood Culture
7%
Social Sciences
contagious disease
22%
confidence
11%
incidence
10%
hypertension
9%
drug
9%
Eastern Europe
7%
blood pressure
6%
Healthcare
5%
AIDS
5%
human being
5%